INOFEA AG is a Swiss biotech company founded in 2014 in Basel by a group of entrepreneurs and scientists as a spin-off from the School of Life Sciences, University of Applied Sciences and Arts, Northwestern Switzerland (FHNW). Their high-quality laboratory is dedicated to develop and manufacture immobilized and shielded enzymes with benefits, other enzyme-technologies do not have.
Fill out the form and discover how you can benefit from enzzen® technology.
The use of enzymes is limited because their structures are sensitive, fragile and often not suitable for process conditions. INOFEA developed a unique, patented technology that unlocks the full potential of enzymes. The enzzen® technology is based on a protective layer enhancing the stability of immobilized enzymes. enzzen® makes enzymes fit for various applications and gives them a seamless level of enhanced properties, unlike any other existing technology.
| Characteristics | Immobilized enzymes | enzzen® enzymes |
|---|---|---|
| Recylability | ✓ | ✓ |
| Minimization of waste, energy consumption | ✓ | ✓ |
| Ease of separation after reaction is completed | ✓ | ✓ |
| Suitability for batch process | ✓ | ✓ |
| Suitability for continuous process | ✓ | ✓ |
| Improved shelf life | X | ✓ |
| Substrate/product channeling and cascade reactions | X | ✓ |
| Increased stability in harsh process conditions | X | ✓ |
| Making organic solvents obsolete and working under mild process conditions | X | ✓ |
| Acquired enantioselectivity | X | ✓ |
